Clinical Trials Logo

Clinical Trial Summary

An observational study of blinatumomab safety and effectiveness, utilisation, and treatment practices.


Clinical Trial Description

The primary objective of this study is to characterize the safety of Blincyto in routine clinical practice. Blincyto effectiveness, medication errors, and utilisation; and select healthcare resource use while using Blincyto will also be described. Safety and effectiveness of Blincyto in specified subgroups of patients will also be assessed. ;


Study Design


Related Conditions & MeSH terms

  • Blincyto Use in Routine Clinical Practice

NCT number NCT03117621
Study type Observational
Source Amgen
Contact
Status Completed
Phase
Start date March 22, 2017
Completion date February 29, 2024